447 related articles for article (PubMed ID: 28384481)
1. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
[TBL] [Abstract][Full Text] [Related]
2. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
[TBL] [Abstract][Full Text] [Related]
3. Dopamine restores cognitive motivation in Parkinson's disease.
McGuigan S; Zhou SH; Brosnan MB; Thyagarajan D; Bellgrove MA; Chong TT
Brain; 2019 Mar; 142(3):719-732. PubMed ID: 30689734
[TBL] [Abstract][Full Text] [Related]
4. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
[TBL] [Abstract][Full Text] [Related]
5. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
6. Impact of Parkinson's disease and dopaminergic medication on adaptation to explicit and implicit visuomotor perturbations.
Mongeon D; Blanchet P; Messier J
Brain Cogn; 2013 Mar; 81(2):271-82. PubMed ID: 23313834
[TBL] [Abstract][Full Text] [Related]
7. Dopamine selectively remediates 'model-based' reward learning: a computational approach.
Sharp ME; Foerde K; Daw ND; Shohamy D
Brain; 2016 Feb; 139(Pt 2):355-64. PubMed ID: 26685155
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
9. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
[TBL] [Abstract][Full Text] [Related]
11. Dopamine is associated with prioritization of reward-associated memories in Parkinson's disease.
Sharp ME; Duncan K; Foerde K; Shohamy D
Brain; 2020 Aug; 143(8):2519-2531. PubMed ID: 32844197
[TBL] [Abstract][Full Text] [Related]
12. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
13. Functional brain activity and presynaptic dopamine uptake in patients with Parkinson's disease and mild cognitive impairment: a cross-sectional study.
Ekman U; Eriksson J; Forsgren L; Mo SJ; Riklund K; Nyberg L
Lancet Neurol; 2012 Aug; 11(8):679-87. PubMed ID: 22742929
[TBL] [Abstract][Full Text] [Related]
14. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
[TBL] [Abstract][Full Text] [Related]
15. The role of dopamine in positive and negative prediction error utilization during incidental learning - Insights from Positron Emission Tomography, Parkinson's disease and Huntington's disease.
Mathar D; Wilkinson L; Holl AK; Neumann J; Deserno L; Villringer A; Jahanshahi M; Horstmann A
Cortex; 2017 May; 90():149-162. PubMed ID: 27751503
[TBL] [Abstract][Full Text] [Related]
16. The role of dopamine in cognitive sequence learning: evidence from Parkinson's disease.
Shohamy D; Myers CE; Grossman S; Sage J; Gluck MA
Behav Brain Res; 2005 Jan; 156(2):191-9. PubMed ID: 15582105
[TBL] [Abstract][Full Text] [Related]
17. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
[TBL] [Abstract][Full Text] [Related]
18. Enhanced motivation of cognitive control in Parkinson's disease.
Timmer MHM; Aarts E; Esselink RAJ; Cools R
Eur J Neurosci; 2018 Sep; 48(6):2374-2384. PubMed ID: 30151991
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic medication normalizes aberrant cognitive control circuit signalling in Parkinson's disease.
Cai W; Young CB; Yuan R; Lee B; Ryman S; Kim J; Yang L; Henderson VW; Poston KL; Menon V
Brain; 2022 Nov; 145(11):4042-4055. PubMed ID: 35357463
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson's disease.
McCoy B; Jahfari S; Engels G; Knapen T; Theeuwes J
Brain; 2019 Nov; 142(11):3605-3620. PubMed ID: 31603493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
